Women Business Connect Global Summit V.I.B.E. 2.0 to Bring Together World-Renowned Leaders, ICF Coaches, and Bestselling Authors for a Two-Day Online Experience

Women Business Connect Global today announced the return of its Global Summit V.I.B.E. 2.0, a two-day virtual gathering that will unite women from every continent for an unparalleled experience in

Read More

Smiland Dental Brings World-Class Dentistry with a Local Touch to Fort Lauderdale and Pembroke Pines

Fort Lauderdale, FL – Smiland Dental, led by renowned dentist Dr. Hassan Al Maghazchi, DMD, DDS, is redefining the dental experience in South Florida. With practices in Fort Lauderdale and Pembroke

Read More

Accountability Now a Business Coaching and Consulting Firm Acquires Noomii.com

St. Johns, FL – Accountability Now, a business coaching and consulting firm, has acquired Noomii.com, one of the coaching industry’s longest-running platforms. This acquisition will expand Noomii beyond its roots

Read More

All-in-One CRM Wealthy CRM Launches to Help Small Business Owners Save Time and Cut Costs

Created by Kerim Gulec, Wealthy CRM is a new all-in-one CRM platform designed to simplify how small businesses and entrepreneurs handle their sales and marketing operations. All-in-One CRM Wealthy CRM

Read More

PRANCE Redefines Interior Design: Metal Wall Panels Outshine Wood in Global Projects

As businesses worldwide reimagine their workplaces, a growing number of architects and developers are turning away from traditional wood finishes and embracing metal wall panel systems for modern interiors. PRANCE

Read More

Vitrectomy Devices Market Intelligence Report: Global Forecast, Regulatory Shifts, and Competitive Insights for Pharma and Device Companies | DelveInsight

Vitrectomy Devices Market Insights, Competitive Landscape, and Market Forecast report DelveInsight projects the Vitrectomy Devices market, valued at USD 1.12B in 2023, to grow at 7.12% CAGR through 2030, driven

Read More

Obesity Treatment Landscape: Teva Launches First Generic GLP-1 Weight Loss Drug | DelveInsight’s Perspective on Market Impact, Competitive Landscape and Pipeline Therapies

Obesity Market Insight, Epidemiology and Market Forecast report DelveInsight Business Research’s latest report highlights the transformative impact of Teva Pharmaceuticals’ FDA approval and U.S. launch of the first-ever generic GLP-1

Read More

Immune Thrombocytopenia Treatment Landscape: FDA Approves WAYRILZ, First BTK Inhibitor | DelveInsight’s Perspective on Market Impact, Competitive Landscape and Pipeline Therapies

Immune Thrombocytopenia Market Insight, Epidemiology and Market Forecast report DelveInsight Business Research’s latest report highlights the transformative impact of the FDA’s approval of WAYRILZ (rilzabrutinib) by Sanofi (Euronext: SAN, NASDAQ:

Read More

Alzheimer’s Disease Treatment: FDA Approves LEQEMBI IQLIK, First Self-Administered Alzheimer’s Therapy | DelveInsight’s Perspective on Market Impact, Competitive Landscape and Pipeline Therapies

Alzheimer’s Disease Market Insight, Epidemiology and Market Forecast report DelveInsight’s latest report highlights the transformative impact of the FDA’s approval of LEQEMBI IQLIK by Eisai Co. and Biogen Inc. (NASDAQ:

Read More

Drug Delivery Devices Market Size, Trends, and Strategic Opportunities Through 2030: Insights for Pharmaceutical and MedTech Stakeholders | DelveInsight

Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast report DelveInsight projects the global Drug Delivery Devices market to grow at a 7.90% CAGR through 2030, driven by rising

Read More

Critical Limb Ischemia Market Outlook 2034 – Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight

Critical Limb Ischemia Market Critical Limb Ischemia companies are Boston Scientific Corporation, AnGes, Inc., Mitsubishi Tanabe Pharma, B. Braun Melsungen AG, Medtronic Endovascular, Ixaka Ltd, Mercator MedSystems, Inc, Hemostemix Inc.,

Read More

Cholangiocarcinoma Market Outlook 2034 – Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight

Cholangiocarcinoma Market Cholangiocarcinoma companies are AstraZeneca, Decalth Systems, Power Life Sciences, Genfit, Servier Affaires Médicales, Basilea Pharmaceutica, Taiho Oncology, Eisai Pharmaceuticals, TransThera Sciences, Incyte Corporation, Roche, Agios Pharmaceuticals, Servier Pharmaceuticals,

Read More

Soft Tissue Sarcoma Clinical Trial Assessment 2025: Investigational Drugs, FDA Approvals, Pipeline Drugs, Therapies, Mechanism of Action, Route of Administration by DelveInsight

Soft Tissue Sarcoma Clinical Trial Assessment Soft Tissue Sarcoma companies working in the treatment market are Advenchen Laboratories, Philogen, Gradalis, Epizyme, Taiho Pharmaceuticals, KaryoPharm Therapeutics, Nanobiotix, Incyte Corporation, AVEO Pharmaceuticals,

Read More

NSCLC Clinical Trials Assessment 2025: Therapeutics Landscape, FDA Approvals, Pipeline Analysis, Competitive Landscape, Therapies, Medication, ROA, MOA by DelveInsight

NSCLC Clinical Trials Assessment NSCLC Companies working in the market include BridgeBio Pharma, Daiichi Sankyo, EMD Serono/Merck, BridgeBio Pharma, Abbvie/Pfizer, Eli Lilly, BioNTech SE, Shenzhen TargetRx, Taiho Pharmaceutical, Chong Kun

Read More

Chronic Inflammatory Demyelinating Polyneuropathy Market Outlook 2034 – Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight

Chronic Inflammatory Demyelinating Polyneuropathy Market CIDP Companies are Takeda, Argenx, Sanofi, Janssen Research and Development, Immunovant Sciences GmbH, HanAll Pharma, Roivant Sciences, Shire, Argenx, Sanofi, Nihon Pharmaceutical, Immunovant Sciences, Octapharma,

Read More

Hepatocellular Carcinoma Clinical Trials Assessment 2025: Competitive Landscape, FDA Approvals, Therapies, Emerging Drugs, Mechanism of Action, Route of Administration by DelveInsight

Hepatocellular Carcinoma Clinical Trials Assessment Hepatocellular Carcinoma companies are Polaris Pharmaceuticals, Sumitomo Pharma, Surface Oncology, Oxford BioTherapeutics, OriCell Therapeutics, Tarus Therapeutics, Tvardi Therapeutics, SCG Cell Therapy, AVEO Oncology, Sinocelltech, GlaxoSmithKline,

Read More

Ocular Hypertension Pipeline Analysis, 2025 by DelveInsight | Santen Pharmaceutical, Nicox Ophthalmics, Inc., Allysta Pharmaceuticals, Qlaris Bio, Inc, Ripple Therapeutics, Laboratoires Thea, Ocular T

Ocular Hypertension Pipeline Analysis DelveInsight’s, “Ocular Hypertension – Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Ocular Hypertension pipeline landscape. It covers the

Read More

Chronic Lymphocytic Leukemia Pipeline Analysis, 2025 by DelveInsight | Loxo Oncology, Oncternal Therapeutics, MingSight Pharmaceuticals, Nurix Therapeutics, Starton Therapeutics, TG therapeutics, Bris

Chronic Lymphocytic Leukemia Pipeline Analysis DelveInsight’s, “Chronic Lymphocytic Leukemia (CLL) – Pipeline Insight, 2025,” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia (CLL)

Read More

Nephrotic Syndrome Pipeline Analysis, 2025 by DelveInsight | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers Squibb, ChemoCentryx, SynAct Pharm

Nephrotic Syndrome Pipeline Analysis DelveInsight’s, “Nephrotic Syndrome Pipeline Insight 2025” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Nephrotic Syndrome pipeline landscape. It covers the pipeline

Read More

Netherton Syndrome Pipeline Analysis, 2025 by DelveInsight | TenNor Therapeutics, KBP Biosciences, Debiopharm, Destiny Pharma

Netherton Syndrome Pipeline Analysis DelveInsight’s, “Netherton Syndrome- Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the pipeline

Read More